Brief: Verastem Oncology Announces Two-Year Median Follow-Up Data On Avmapki® Fakzynja® Combination Therapy
10/04/2026 12:07
April 10 (Reuters) - Verastem Inc VSTM.O: VERASTEM ONCOLOGY ANNOUNCES TWO-YEAR MEDIAN FOLLOW-UP DATA ON AVMAPKI® FAKZYNJA® COMBINATION THERAPY (AVUTOMETINIB CAPSULES; DEFACTINIB TABLETS) IN RECURRENT LOW-GRADE SEROUS OVARIAN CANCER AT THE SGO 2026 ANNUAL MEETING ON WOMEN’S CANCERS Source text: ID:nBw55tsBpa Further company coverage: VSTM.O ((Reuters.Briefs@thomsonreuters.com;))